Jagat Pharma gets WHO-GMP, CoPP certification for ayurvedic eye drops

May 24, 2023 | Wednesday | News

Focusing to continue advanced medicinal research and come up with new products

In a major feat to establish itself as one of the leading companies in Ayurveda, Uttar Pradesh-based Jagat Pharma has now been accredited with the WHO-GMP (World Health Organisation - Good Manufacturing Practices) certificate and Certificate of Pharmaceutical Products (CoPP) for its groundbreaking invention – the Isotine Plus ayurvedic eye drops.

This is the first time any Ayurvedic eye drop manufactured in the country has received the WHO-GMP certificate and (CoPP) certificate. 

The Isotine Plus ayurvedic eye drops by Jagat Pharma have been clinically used for 36 years with a track record to reverse cataract-induced visual impairment. The eye drops are used to treat complex eye diseases like Cataracts, Macular Degeneration, Myopia, Hypermetropia, Glaucoma, Diabetic Retinopathy, Retinitis Pigmentosa, etc.

Some of the most unique ayurvedic ingredients used in the Isotine Plus ayurvedic eye drops include Chandan (Santalum album), Apamarg (Achyranthes aspera), Fennel (Foeniculum vulgare), Punarnava (Boerhaviadiffusa), Bhringaraj (Ecliptaprostrata), Arjuna (Terminalia arjuna), and Satva Pudina (Mentha piperita), to name a few.

With growing popularity and impressive outcomes, around 10 lakh units of the Isotine Plus Ayurvedic eye drops have been sold during 2022-2023. Presently, Jagat Pharma is exporting the Isotine Plus eye drops to Cambodia and Russia and the company has plans to expand its export business to other nations like Germany, Hong Kong, Japan, UAE, Thailand, and Taiwan.

 

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy